title: Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users.
abstract: OBJECTIVE
  The aim of the present study was to measure the treatment of menorrhagia and health-related quality of life (QoL) in Levonorgestrel-releasing intrauterine system (LNG-IUS) in Turkish women.
  
  
  METHODS
  We recruited 66 premenopausal women, aged 26-55 years, who had sought care in the previous year for menorrhagia. All patients were asked to complete a visual analog scale (VAS) form regarding pelvic pain, sexual life (libido) and general feeling of health. Patients filled the VAS form before LNG-IUS insertion and after 6 months.
  
  
  RESULTS
  After the 6-month visit, PBAC score was condirebly decreased (p < 0.001). Six (10%) of the 60 patients PBAC score was higher than 75. VAS score for pelvic pain decreased from baseline to 6-month follow-up (4.32-3.55), and the libido and general feeling of health increased (4.27-4.95 and 3.47-6.87, respectively).
  
  
  CONCLUSIONS
  The LNG-IUS device in the trearment of menorrhagia has cost effective, less side effects and increse in the QoL.
authors.affiliation: Department of Obstetrics and Gynecology, Haseki Education and Research Hospital, Istanbul, Turkey. husnugorgen@yahoo.com
authors.forename: Husnu
authors.initials: H
authors.lastname: Gorgen
authors.forename: Murat
authors.initials: M
authors.lastname: Api
authors.forename: Aysu
authors.initials: A
authors.lastname: Akça
authors.forename: Ahmet
authors.initials: A
authors.lastname: Cetin
mesh_terms: D000328:Adult; D003280:Contraceptives, Oral, Synthetic / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007436:Intrauterine Devices, Medicated; D016912:Levonorgestrel / Q000008:administration & dosage; D008595:Menorrhagia / Q000628:therapy*; D008875:Middle Aged; D011788:Quality of Life; D014421:Turkey
chemical_list: D003280:Contraceptives, Oral, Synthetic; D016912:Levonorgestrel